Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNN4 | O15554 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.31 |
| ▸ | IDO1 | P14902 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3111885 | 0.89 | KCNN4 (0.46) | KCNN4TDP1 | |
| SCHEMBL27669506 | 0.76 | TDP1 (0.42) | TDP1TAAR1IDO1 | |
| SCHEMBL3435481 | 0.76 | KCNN4 (0.50) | KCNN4TAAR1 | |
| SCHEMBL7263746 | 0.74 | KIF11 (0.41) | KCNN4TDP1TAAR1 | |
| SCHEMBL30252413 | 0.72 | IDO1 (0.52) | TDP1IDO1 | |
| SCHEMBL3126891 | 0.72 | IDO1 (0.52) | TDP1IDO1 | |
| Ammonia Solution, Strong SCHEMBL27704287 | 0.71 | IDO1 (0.50) | TDP1IDO1 | |
| SCHEMBL17938005 | 0.71 | CHRM2 (0.48) | KCNN4 | |
| SCHEMBL30600 | 0.70 | TDP1 (0.55) | TDP1TAAR1IDO1 | |
| SCHEMBL14830410 | 0.69 | KCNN4 (0.43) | KCNN4TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090012054-A1 | Cephem Compounds and Use as Antimicrobial Agents | ASTELLAS PHARMA INC. (JP) | 2009-01-08 | — | — | US | disclosed |
| EP-1994035-A1 | CEPHEM COMPOUNDS AND USE AS ANTIMICROBIAL AGENTS | Astellas Pharma Inc. (JP) | 2008-11-26 | — | — | EP | disclosed |
| WO-2007119511-A1 | CEPHEM COMPOUNDS AND USE AS ANTIMICROBIAL AGENTS | ASTELLAS PHARMA INC. (JP) | 2007-10-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090012054-A1 | Cephem Compounds and Use as Antimicrobial Agents | CEP170, Q6ZSR9, H1-10 | KCNN4 2057/4885TDP1 4453/4885TAAR1 1749/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.